News

November 28, 2025

A Different Type of Dementia Is Changing What’s Known About Cognitive Decline

Source: The New York Times

November 21, 2025

Kannampallil, Wiley named medical informatics fellows

WashU Medicine researchers recognized for significant contributions to data science.

National Leaders

October 23, 2025

Alzheimer’s disrupts circadian rhythms of plaque-clearing brain cells

Mouse study shows how disease reprograms genes in specialized cells involved in amyloid removal.

News Release

October 15, 2025

Klinman recognized as outstanding early-career scientist

Neurologist specializing in movement disorders and neurodegeneration named 2025 STAT Wunderkind.

National Leaders

October 14, 2025

He carries the Alzheimer’s gene but never got the disease — scientists want to know why

Source: Fox News

October 13, 2025

Smyser named director of the Division of Pediatric & Developmental Neurology

Pediatric neurologist is a national leader in neuroimaging, infant brain development.

Medical Campus & Community

September 1, 2025

Study sheds light on how pediatric brain tumors grow

Blocking a chemical messenger in the brain that helps tumor cells multiply could offer new route to treatment.

News Release

August 14, 2025

New method more accurately assesses movement disorder in children

Study on cerebral palsy in humans and mice could inform new treatments.

News Release

July 14, 2025

WashU Medicine selected for Parkinson’s disease training program

Edmond J. Safra Fellowship to fund training of movement disorder specialist in the Department of Neurology.

Medical Campus & Community, National Leaders

June 28, 2025

Three Siblings, One Fatal Gene: A Family’s Fight Against Early-Onset Alzheimer’s

Source: The Wall Street Journal

May 27, 2025

Sleep aid blocks neurodegeneration in mice

Lemborexant, similar sleep drugs show promise in treating disorders related to tau, such as Alzheimer’s disease.

News Release

May 16, 2025

‘Ancient’ brainstem structure evolved beyond basic motor control

Source: The Transmitter

May 12, 2025

Drug to slow Alzheimer’s well tolerated outside of clinical trial setting

Side effects of lecanemab are manageable, study finds.

News Release

March 31, 2025

Highly accurate blood test diagnoses Alzheimer’s disease, measures extent of dementia

Could help determine which patients are likely to benefit from new Alzheimer’s drugs.

News Release

March 19, 2025

Anti-amyloid drug shows signs of preventing Alzheimer’s dementia

Clinical trial of people destined to develop early-onset Alzheimer’s disease shows eliminating amyloid from brain may prevent symptoms, supports need for confirmatory studies.

News Release

March 7, 2025

$4.5 million supports pathbreaking neuroimmunology research

Grant funds WashU Medicine’s pursuit of new treatments for Alzheimer’s disease.

News Release

March 4, 2025

WashU School of Medicine study examines disparities in genetic testing in Black children

Source: St. Louis Public Radio

February 13, 2025

Study highlights barriers to genetic testing for Black children

WashU Medicine’s pediatric neurology uses findings to improve testing access for kids with suspected genetic disorders.

News Release

February 12, 2025

His genes forecast Alzheimer’s. His brain had other plans.

Source: National Public Radio

February 10, 2025

Patient defies genetic fate to avoid Alzheimer’s

Study offers clues to treatment, prevention.

News Release

February 4, 2025

New study will try to stop Alzheimer’s decades before it begins, using experimental Eli Lilly drug

Source: Endpoints News

February 4, 2025

International Alzheimer’s prevention trial in young adults begins

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise.

News Release